Proteomics

Dataset Information

0

Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and 6 extracellular vesicles recycling


ABSTRACT: Next generation modified antisense oligonucleotides (ASOs) are commercially approved new therapeutic modalities, yet poor productive uptake and endosomal entrapment in tumour cells limit their broad application. We compared intracellular traffic of anti KRAS antisense oligonucleotide (AZD4785) in good and poor productive uptake tumour cells, PC9 and LK2 respectively. We found that the majority of AZD4785 is rapidly delivered to CD63+ late endosomes (LE) in both cell lines. Importantly, lysobisphosphatidic acid (LBPA) that triggers ASO LE escape is presented in CD63+ LE in PC9 but not in LK2 cells. Moreover, both cells recycle AZD4785 in the extracellular vesicles (EVs) however AZD4785 quantification by advanced mass spectrometry and proteomic analysis revealed that LK2 recycles more AZD4785 and RNA-binding proteins. Finally, stimulating LBPA intracellular production or blocking EV recycling enhanced AZD4785 activity in LK2 but not in PC9 cells thus offering novel strategy to possibly enhance ASO potency in poor productive uptake tumour cells.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Nitin Rustogi  

LAB HEAD: Nicholas J Bond

PROVIDER: PXD027804 | Pride | 2021-11-10

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Human_Dec2020_Swissprot.fasta Fasta
LK2_ASO.xlsx Xlsx
LK2_CONTROL.xlsx Xlsx
PC9_ASO.xlsx Xlsx
PC9_Control.xlsx Xlsx
Items per page:
1 - 5 of 23

Similar Datasets

2022-04-26 | GSE201237 | GEO
2023-05-15 | GSE220777 | GEO
2015-01-23 | E-GEOD-61957 | biostudies-arrayexpress
2015-08-12 | E-GEOD-60189 | biostudies-arrayexpress
2016-09-08 | E-GEOD-77936 | biostudies-arrayexpress
2024-01-09 | GSE242020 | GEO
2024-01-09 | GSE242017 | GEO
2015-01-23 | GSE61957 | GEO
2022-05-30 | GSE198864 | GEO
2019-02-26 | GSE125108 | GEO